CorVad Percutaneous Ventricular Assist System

DEVICE3 trials

Sponsors

Shenzhen Core Medical Technology CO.,LTD.

Conditions

Cardiogenic ShockCoronary Artery DiseaseRight Heart Failure

Unknown Phase

CorVad Percutaneous Ventricular Assist System Study

Shenzhen Core Medical Technology CO.,LTD.Coronary Artery Disease

Start: 2023-10-19End: 2024-10-18Target: 120Updated: 2024-01-10

Efficacy and Safety of the CorVad Percutaneous Ventricular Assist System in Cardiogenic Shock

RecruitingNCT06646224

Shenzhen Core Medical Technology CO.,LTD.Cardiogenic Shock

Start: 2024-10-12End: 2025-05-31Target: 50Updated: 2024-10-17

Safety and Feasibility of the CorVad Percutaneous Ventricular Assist System in Refractory Right Heart Failure

RecruitingNCT07704424

Shenzhen Core Medical Technology CO.,LTD.Right Heart Failure

Start: 2026-06-02End: 2027-02-28Target: 6Updated: 2026-07-15